4D Molecular Therapeutics (FDMT) Profit After Tax (2020 - 2025)
Historic Profit After Tax for 4D Molecular Therapeutics (FDMT) over the last 6 years, with Q3 2025 value amounting to -$56.9 million.
- 4D Molecular Therapeutics' Profit After Tax fell 2972.65% to -$56.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$209.2 million, marking a year-over-year decrease of 4578.83%. This contributed to the annual value of -$160.9 million for FY2024, which is 5953.27% down from last year.
- Per 4D Molecular Therapeutics' latest filing, its Profit After Tax stood at -$56.9 million for Q3 2025, which was down 2972.65% from -$54.7 million recorded in Q2 2025.
- 4D Molecular Therapeutics' 5-year Profit After Tax high stood at -$7.6 million for Q2 2021, and its period low was -$56.9 million during Q3 2025.
- In the last 5 years, 4D Molecular Therapeutics' Profit After Tax had a median value of -$28.7 million in 2023 and averaged -$31.6 million.
- As far as peak fluctuations go, 4D Molecular Therapeutics' Profit After Tax surged by 6007.94% in 2023, and later crashed by 32748.63% in 2024.
- Over the past 5 years, 4D Molecular Therapeutics' Profit After Tax (Quarter) stood at -$25.1 million in 2021, then dropped by 9.15% to -$27.4 million in 2022, then fell by 17.91% to -$32.3 million in 2023, then crashed by 53.86% to -$49.7 million in 2024, then fell by 14.51% to -$56.9 million in 2025.
- Its Profit After Tax stands at -$56.9 million for Q3 2025, versus -$54.7 million for Q2 2025 and -$48.0 million for Q1 2025.